When your literature search produces hundreds or even thousands of results, you may find yourself having to look up each gene individually – and the process quickly goes from painstakingly slow to impossible.
With BioReflect, we have designed an at-a-glance and up-to-date global overview of publications, with topic-based clustering that lets you breeze through your literature searches with ease and in an unbiased manner. BioReflect can fast-track your preparation for regulatory approval or exploratory reading by helping you to select the most important relevant scientific literature, and by easily linking literature directly to your data for easy scientific exploration.
In addition, BioReflect seamlessly integrates disease, gene and chemical annotations in its reported results, and therefore can help reveal gene-disease associations and more from publications. BioReflect is a valuable tool across your project lifecycles – from initial exploration phases to patents and clinical trial searches.
Oncology drug development often begins in patients, allowing early safety and efficacy insights. Yet many cancer drugs still fail in the clinic. We validate the target but ignore its context within the tumor microenvironment. This article explores why spatial biology may improve clinical success.
BioLizard has been named “Bioinformatics Innovation of the Year” in the 2025 BioTech Breakthrough Awards. The honor spotlights Bio|Verse® Navigator, a visual analytics workspace that unifies complex R&D data so scientists can decide faster, with confidence.
Bioinformatics pipelines break for the smallest reasons: package updates, shifting dependencies, or “it only works on my machine.” This post explains why experienced software engineers and DevOps practices (Git, CI/CD, IaC) are essential to keep workflows reproducible, stable, and scalable.
